Measures · D08 in 2017 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 02/2016 – 08/2016
- Better when
- Higher
- Weight
- 1.5 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- No
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2015. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
From the 2017 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2017 star distribution
Not rated: Plan too small to be measured (122); Plan too new to be measured (61); Plan not required to report measure (13); Not enough data available (1)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2017
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S6506 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | — | 74 | 1 | 0 | 9 | 0% |
| H1894 Wellpoint | Elevance Health, Inc. | 2,322 | 74 | 1 | — | 10 | 0% |
| H3312 Aetna Medicare | CVS Health Corporation | 105,069 | 75 | 1 | 0 | 9 | 0% |
| H3370 EMPIRE HEALTHCHOICE HMO, INC. | Anthem Inc. | — | 76 | 1 | 0 | 8 | 1% |
| H5793 Aetna Medicare | CVS Health Corporation | 63,182 | 77 | 1 | −1 | 7 | 1% |
| H3307 UnitedHealthcare | UnitedHealth Group, Inc. | — | 77 | 1 | −1 | 7 | 1% |
| H5530 ANTHEM HEALTH PLANS OF KENTUCKY, INC. | Anthem Inc. | — | 78 | 1 | 0 | 6 | 1% |
| H8649 Aetna Medicare | CVS Health Corporation | 1,503 | 78 | 1 | 0 | 6 | 1% |
| H0294 UnitedHealthcare | UnitedHealth Group, Inc. | 71,413 | 78 | 1 | 0 | 6 | 1% |
| H1692 Aetna Medicare | CVS Health Corporation | 21,626 | 78 | 1 | 0 | 6 | 1% |
| H8552 Anthem Blue Cross Life and Health Insurance Company | Elevance Health, Inc. | 1,065 | 78 | 1 | 0 | 6 | 1% |
| R3332 Florida Blue | Guidewell Mutual Holding Corporation | — | 78 | 1 | 0 | 6 | 1% |
| H5141 Clover Health | Clover Health Holdings, Inc. | 156,154 | 78 | 1 | −2 | 6 | 1% |
| H7245 Premera Blue Cross Medicare Advantage | Premera | — | 78 | 1 | −1 | 6 | 1% |
| H1302 Blue Cross of Idaho | Gemstone Holdings, Inc. | 3,795 | 78 | 1 | −1 | 6 | 1% |
| S5904 Florida Blue | Guidewell Mutual Holding Corporation | 46,802 | 77 | 1 | −1 | 6 | 2% |
| S1140 Highmark Blue Cross Blue Shield or Highmark Blue Shield | Highmark Health | 3,185 | 77 | 2 | +1 | 6 | 2% |
| S5921 UnitedHealthcare | UnitedHealth Group, Inc. | 2,326,418 | 77 | 1 | −2 | 6 | 2% |
| H1286 Unitedhealthcare Insurance Company | UnitedHealth Group, Inc. | — | 79 | 1 | −1 | 5 | 4% |
| H3655 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 142,647 | 79 | 1 | −1 | 5 | 4% |
| H5520 HEALTH NET LIFE INSURANCE COMPANY | Centene Corporation | — | 79 | 1 | −3 | 5 | 4% |
| H9190 Gateway Health Plan Of Ohio, Inc. | Gateway Health Plan, LP | — | 79 | 2 | — | 5 | 4% |
| H9947 BLUE CROSS AND BLUE SHIELD OF GEORGIA, INC. | Anthem Inc. | — | 79 | 1 | −1 | 5 | 4% |
| H5009 Regence BlueShield | Cambia Health Solutions, Inc. | 10,384 | 79 | 1 | 0 | 5 | 4% |
| H2816 Wellcare | Centene Corporation | 1,757 | 79 | 1 | — | 5 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |